PARP-1 as a novel target in endocrine-resistant breast cancer
Overall, our results suggest that PARP-1 should be explored as a potential target in comprehensive therapeutic approaches in ET-resistant BC.
Authors
- Geoffrey L. Greene (ORCID: https://orcid.org/0000-0001-6894-8728)
- Rosamaria Lappano (ORCID: https://orcid.org/0000-0002-9374-9701)
- Azzurra Zicarelli
- Marianna Talia (ORCID: https://orcid.org/0000-0002-3440-5618)
- Marcello Maggiolini (ORCID: https://orcid.org/0000-0002-7485-854X)
- Muriel Lainé (ORCID: https://orcid.org/0000-0002-4791-5959)
Institutions
- University of Chicago (US)
- University of Calabria (IT)
Publication Details
- Journal
- Journal of Experimental & Clinical Cancer Research
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1186/s13046-025-03441-4
- Citations
- 4
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- University of Chicago